Just diagnosed with MIT family translocation renal cell carcinoma?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees MIT family translocation renal cell carcinoma, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive MIT family translocation renal cell carcinoma hub →Overview
MIT family translocation renal cell carcinoma is a rare condition. Also known as Carcinoma associated with MITF/TFE translocation, Translocation renal cell carcinoma. Tomeko brings together the specialists, research, clinical trials, treatments and community for MIT family translocation renal cell carcinoma so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:319308 · OMIM 300854 · ICD-10 C64 · GARD 0017446
Find care for MIT family translocation renal cell carcinoma
Authoritative references for MIT family translocation renal cell carcinoma
Research & market landscape for MIT family translocation renal cell carcinoma
Following MIT family translocation renal cell carcinoma for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for MIT family translocation renal cell carcinoma — the real-world landscape behind the condition, in one place.
- Latest MIT family translocation renal cell carcinoma research on PubMed ↗
- Recruiting MIT family translocation renal cell carcinoma trials on ClinicalTrials.gov ↗
- Explore the MIT family translocation renal cell carcinoma research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for MIT family translocation renal cell carcinoma and every rare condition. See how Tomeko works with industry →
Common questions
What is MIT family translocation renal cell carcinoma?
MIT family translocation renal cell carcinoma is a rare condition. Also known as Carcinoma associated with MITF/TFE translocation, Translocation renal cell carcinoma. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for MIT family translocation renal cell carcinoma together in one place.
What are the symptoms of MIT family translocation renal cell carcinoma?
Symptoms of MIT family translocation renal cell carcinoma vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats MIT family translocation renal cell carcinoma.
How is MIT family translocation renal cell carcinoma treated?
Treatment for MIT family translocation renal cell carcinoma depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see MIT family translocation renal cell carcinoma, and review current options with them.
What causes MIT family translocation renal cell carcinoma — is it genetic?
The cause and inheritance of MIT family translocation renal cell carcinoma are described in the authoritative references linked on this page. A genetics or specialist clinician who treats MIT family translocation renal cell carcinoma can explain what it means for you and your family.
I was just diagnosed with MIT family translocation renal cell carcinoma — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees MIT family translocation renal cell carcinoma, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for MIT family translocation renal cell carcinoma?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat MIT family translocation renal cell carcinoma, filtered to your area.
Are there clinical trials for MIT family translocation renal cell carcinoma?
Tomeko shows live, recruiting studies for MIT family translocation renal cell carcinoma from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: